Tara O. Henderson, MD, MPH, FASCO Professor of Pediatrics Director, Childhood, Adolescent and Young Adult Survivorship Center Director, Cancer Survivorship and Co-Leader, Cancer Prevention and Control Program Comprehensive Cancer Center The University of Chicago Chicago, IL

Tara O. Henderson, MD, MPH, FASCO is a Professor of Pediatrics, Interim Section Chief of Hematology, Oncology and Stem Cell Transplantation, Director of the Childhood Cancer Survivor Center at the University of Chicago, and co-leader of the cancer prevention and control program for the University of Chicago Comprehensive Cancer Center. Dr. Henderson is an expert in the treatment and outcomes of adolescents and young adults with lymphoma, and in the long-term outcomes of childhood, adolescent and young adult cancer survivors. She is a federally funded investigator focused in understanding subsequent cancer and other late effects in survivors and in developing interventions to increase screening and early detection of these subsequent cancers.

Danielle Novetsky Friedman, MD, MS Assistant Member Pediatric Long-Term Follow-Up Program Memorial Sloan Kettering Cancer Center New York, NY

Danielle Novetsky Friedman, MD, MS is a pediatrician who specializes in survivorship and late effects after childhood cancer therapy. Dr. Friedman completed her undergraduate degree at Columbia; medical school at Albert Einstein College of Medicine; residency in Pediatrics at Cornell, and Chief Residency and Fellowship in pediatric cancer survivorship, both at Memorial Sloan Kettering Cancer Center. She also holds master's degrees in Theological Studies/Ethics from Harvard University and Clinical and Translational Research from Cornell University. She currently divides her time between the clinical care of survivors of childhood cancer and blood disorders, who are one or more years after completion of therapy, and clinical research focused on radiation-related late effects. Her goal is to provide comprehensive, state-of-the-art survivorship care, informed by novel research findings, to improve the lives of survivors of all childhood cancers and blood disorders.